 Home > Active Ingredient News > Drugs Articles > Bayer poachs another GSK executive to lead its strategic oncology business unit

Bayer poachs another GSK executive to lead its strategic oncology business unit

 Last Update: 2022-05-30
 Source: Internet
 Author: User

Tags

research plan outline

alphamab oncology

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Bayer has appointed Dr.

Both Tara Frenkl and Christine Roth were previously at GSK, with Frenkl previously serving as senior vice president and head of oncology drug development at GSK, while Roth was a senior GSK global oncologist before joining Bayer on March 1.

It is reported that Bayer's Prescription Drugs Division focuses on the field of cardiovascular diseases and is currently strengthening its foothold in the field of oncology, investing heavily in expanding research and development pipelines, and collaborating with a number of gene therapy companies

At Bayer, Roth and Frenkl will focus on developing the prostate cancer drug Nubeqa

Bayer's third-quarter 2021 results show that Nubeqa's sales have grown slowly and it did not make the top 20 drug list

Currently, Bayer is conducting clinical trials of Nubeqa in prostate cancer indications

Notably, Bayer's prostate cancer radiotherapy drug Xofigo is a powerful addition to Nubeqa and has been approved for the treatment of castration-resistant prostate cancer, symptomatic bone metastases and patients with no known visceral metastatic disease

Original in English: https:// href="https://" target="_blank">https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.